prikaz prve stranice dokumenta Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm
  Preuzmi
PDF 261.6 KB
Znanstveni rad - Pregledni rad
Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm
Journal of Clinical Medicine, 11 (2022), 23; 7101. https://doi.org/10.3390/jcm11237101
Šipuš, Dubravka; Krželj, Kristina; Đurić, Željko; Gašparović, Hrvoje; Miličić, Davor; Hanževački, Jadranka Šeparović; Lovrić, Daniel

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Šipuš, D., Krželj, K., Đurić, Ž., Gašparović, H., Miličić, D., Hanževački, J. Š. i Lovrić, D. (2022). Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm. Journal of Clinical Medicine, 11. (23). doi: 10.3390/jcm11237101

Šipuš, Dubravka, et al. "Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm." Journal of Clinical Medicine, vol. 11, br. 23, 2022. https://doi.org/10.3390/jcm11237101

Šipuš, Dubravka, Kristina Krželj, Željko Đurić, Hrvoje Gašparović, Davor Miličić, Jadranka Šeparović Hanževački i Daniel Lovrić. "Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm." Journal of Clinical Medicine 11, br. 23 (2022). https://doi.org/10.3390/jcm11237101

Šipuš, D., et al. (2022) 'Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm', Journal of Clinical Medicine, 11(23). doi: 10.3390/jcm11237101

Šipuš D, Krželj K, Đurić Ž, Gašparović H, Miličić D, Hanževački JŠ, i sur.. Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm. Journal of Clinical Medicine [Internet]. 30.11.2022. [pristupljeno 26.11.2024.];11(23). doi: 10.3390/jcm11237101

D. Šipuš, et al., "Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm", Journal of Clinical Medicine, vol. 11, br. 23, Studeni 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:131775. [Citirano: 26.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:131775
Podaci o radu
Naslov (engleski)Veno-Arterial Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant—Change of Paradigm
AutorDubravka Šipuš
MBZ: 155684
AutorKristina Krželj
AutorŽeljko Đurić
AutorHrvoje Gašparović
AutorDavor Miličić
AutorJadranka Šeparović Hanževački
AutorDaniel Lovrić
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA KIRURGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Kirurgija
Sažetak (engleski)
Despite advances in medical therapy and mechanical circulatory support (MCS), heart transplant (HT) remains the gold standard therapy for end-stage heart failure. Patients in cardiogenic shock require prompt intervention to reverse hypoperfusion and end-organ damage. When medical therapy becomes insufficient, MCS should be considered. Historically, it has been reported that critically ill patients bridged with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) directly to HT have worse outcomes. However, when the heart allocation system gives the highest priority to patients on VA-ECMO support, those patients have a higher incidence of HT and a lower incidence of death or removal from the transplant list. Moreover, patients with a short waiting time on VA-ECMO have a similar hazard of mortality to non-ECMO patients. According to the reported data, bridging with VA-ECMO directly to HT may be a solution in the selection of critically ill patients when the anticipated waiting list time is short. However, when a prolonged waiting time is expected, more durable MCS should be considered. Regardless of the favorable results of the direct bridging to HT with ECMO in selected patients, the superiority of this strategy compared to the bridge-to-bridge strategy (ECMO to durable MCS) has not been established and further studies are mandatory in order to clarify this issue.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaJournal of Clinical Medicine
Brojčani podacivol. 11, br. 23, 7101
e-ISSN2077-0383
DOIhttps://doi.org/10.3390/jcm11237101
URN:NBNurn:nbn:hr:105:131775
Datum objave publikacije2022-11-30
URL dokumentahttps://www.mdpi.com/2077-0383/11/23/7101
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2023-05-17 12:04:53